Sabra Healthcare REIT (NASDAQ:SBRA) Now Covered by Huntington

Equities research analysts at Huntington began coverage on shares of Sabra Healthcare REIT (NASDAQ:SBRA) in a note issued to investors on Thursday, Briefing.com reports. The firm set an “outperform” rating and a $23.00 price target on the real estate investment trust’s stock. Huntington’s price target points to a potential upside of 10.63% from the stock’s current price.

SBRA has been the subject of several other research reports. Truist Financial boosted their price objective on Sabra Healthcare REIT from $22.00 to $24.00 and gave the company a “buy” rating in a research report on Wednesday, July 22nd. Raymond James Financial upgraded shares of Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a report on Thursday, August 6th. Weiss Ratings downgraded shares of Sabra Healthcare REIT from a “buy (b)” rating to a “hold (c+)” rating in a research note on Tuesday, August 4th. Citizens Jmp upped their price target on shares of Sabra Healthcare REIT from $23.00 to $25.00 and gave the company a “market outperform” rating in a report on Wednesday, July 22nd. Finally, Wells Fargo & Company increased their price target on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research report on Monday, June 1st. Seven research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat, Sabra Healthcare REIT has a consensus rating of “Moderate Buy” and a consensus price target of $22.23.

Sabra Healthcare REIT Stock Performance

Sabra Healthcare REIT stock opened at $20.79 on Thursday. Sabra Healthcare REIT has a fifty-two week low of $17.17 and a fifty-two week high of $22.77. The company has a debt-to-equity ratio of 0.95, a quick ratio of 3.07 and a current ratio of 3.07. The stock has a market cap of $5.31 billion, a P/E ratio of 79.96, a price-to-earnings-growth ratio of 1.58 and a beta of 0.65. The firm’s fifty day moving average price is $20.68 and its 200-day moving average price is $20.20.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by ($0.27). Sabra Healthcare REIT had a return on equity of 2.34% and a net margin of 7.61%.The company had revenue of $230.11 million during the quarter, compared to analysts’ expectations of $219.39 million. During the same quarter last year, the firm posted $0.38 earnings per share. The firm’s revenue was up 24.7% on a year-over-year basis. On average, equities research analysts expect that Sabra Healthcare REIT will post 1.52 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO Richard Matros sold 200,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $20.83, for a total transaction of $4,166,000.00. Following the transaction, the chief executive officer directly owned 1,657,686 shares of the company’s stock, valued at approximately $34,529,599.38. The trade was a 10.77% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 1.09% of the company’s stock.

Institutional Trading of Sabra Healthcare REIT

Several large investors have recently added to or reduced their stakes in SBRA. Rothschild Investment LLC raised its holdings in Sabra Healthcare REIT by 164.6% in the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after purchasing an additional 889 shares in the last quarter. Smartleaf Asset Management LLC boosted its holdings in shares of Sabra Healthcare REIT by 97.7% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 714 shares in the last quarter. Versant Capital Management Inc grew its position in shares of Sabra Healthcare REIT by 70.0% in the 2nd quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock worth $29,000 after buying an additional 603 shares during the period. Danske Bank A S purchased a new stake in shares of Sabra Healthcare REIT in the 3rd quarter worth about $30,000. Finally, Larson Financial Group LLC increased its stake in shares of Sabra Healthcare REIT by 42.3% in the 3rd quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after acquiring an additional 553 shares in the last quarter. Institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.